about
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelIntegration of multiparametric MRI into active surveillance of prostate cancer.Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation.B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging.Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus projectApparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate CancerMassive gas gangrene secondary to occult colon carcinoma.Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?Detection of renal lesion enhancement with dual-energy multidetector CT.Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.MDCT evaluation of the pancreas: nuts and bolts.Gradient shimming during magnetic resonance imaging of the liver: comparison of a standard protocol versus a novel reduced protocol.Bone marrow enhancement during time-resolved magnetic resonance angiography of the pelvis.MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.How the radiologist can add value in the evaluation of the pre- and post-surgical pancreas.Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls.Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.Characterization of Small Focal Renal Lesions: Diagnostic Accuracy with Single-Phase Contrast-enhanced Dual-Energy CT with Material Attenuation Analysis Compared with Conventional Attenuation Measurements.The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?Imaging Advances in Urolithiasis.Practice and quality improvement: successful implementation of TeamSTEPPS tools into an academic interventional ultrasound practice.LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique.Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.Dual-energy CT for characterization of adrenal nodules: initial experience.Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis?Effect of radiologists' experience with an adaptive statistical iterative reconstruction algorithm on detection of hypervascular liver lesions and perception of image quality.Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI.Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
P50
Q27006744-65588DEB-857B-4A58-B8D7-30CD384F0100Q30249514-C8A63A67-A67E-4B4A-B06A-097B81D5E64EQ30300480-EE258473-9933-4AE6-A4BD-6F725616DDFCQ30355460-0491E85C-FDB3-41F3-8654-A539F44DB584Q30395077-6A99AE99-9452-45EA-99F4-C5E3DCD014BDQ33580964-D0A9FE3D-ADAC-480B-912B-A570AC244E57Q36727030-4B7553C8-463B-4DFC-B341-6423D8BD7015Q36932220-0A0938BB-6C30-460F-8B7B-4BC919276C97Q37736158-4B5D9D72-7372-4C70-956B-395D4F36CB9CQ37835583-0E04BE96-AAE0-4860-9CC6-FC2EB4A129C0Q37896319-6C9BBE2E-1093-4B0F-B2BF-D23F7B26E145Q37940670-6EA0A2F0-AC84-48A6-8E9B-10D05D37D322Q38007701-C672EEBB-078B-4DEB-8AFE-14BD79C65B09Q38032132-61498B50-F6D4-4324-A396-B9D332CF668EQ38106880-6319A9C6-E02F-44F3-AFB1-73E86B02AEEDQ38116060-3DE0A0B4-FC08-48B8-83B2-99694E5D3922Q38215053-D3952B9E-EBFB-4F73-8430-06061DCDC870Q38611312-3123A85B-397C-470B-B987-A217FF3436C8Q38634786-42B0F9B9-02CC-4DAB-B978-411A1A0F892AQ38664945-B4687CE4-ED55-4E67-B6D3-112F8C79E22CQ38739753-1C35B3C6-D178-468C-9E16-2C8615EE81DAQ38795460-CE1E269A-220B-4BB8-998F-A9EBCCBE1ABAQ38837797-9B5B1E15-4F6B-48BD-BDED-722F0DC547EFQ39177286-AB714A75-B2FF-4AF4-BB21-E21F37762EDBQ39206550-82524BFD-AAAB-4619-930D-92D40F4AF47EQ39356191-A2522D3F-4B04-45ED-9110-22A215A4E103Q40254577-7DBA0DCE-F4C4-4037-9F7A-A095B43A7AF1Q40365789-1A843772-4982-467D-B0F7-1D7FEAB763B3Q40460643-7C8E99AC-2826-42EE-9062-A82355E94EFBQ41651723-CB22E182-C984-4EE2-8FE5-1106E58E5E0CQ43906532-E12917B7-885C-44AE-BC81-31D790C39466Q45056805-645B8B66-D632-45A6-9960-A32027AA490CQ45262316-57EACEE3-AF05-4050-8089-63FDD899E812Q46440158-57DDCCCF-9BF4-484D-97E3-E4DFCA155F51Q46699828-A4FA9A13-CC95-4115-9B96-0456530E3C02Q46964311-D45F4BAB-4C77-4E2D-A015-D1576D4EE975Q50157731-8B91DC11-B553-49BC-A2E8-3B28D5E4B8DBQ50946664-D6EDB6C7-981F-4D42-99F5-2A1B416EAFD0Q51170426-12D467F2-E29F-4B32-B162-8591A78208C5Q51271250-64C1E708-7ECB-4897-B963-22102F2523BE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rajan T Gupta
@ast
Rajan T Gupta
@en
Rajan T Gupta
@es
Rajan T Gupta
@nl
Rajan T Gupta
@sl
type
label
Rajan T Gupta
@ast
Rajan T Gupta
@en
Rajan T Gupta
@es
Rajan T Gupta
@nl
Rajan T Gupta
@sl
prefLabel
Rajan T Gupta
@ast
Rajan T Gupta
@en
Rajan T Gupta
@es
Rajan T Gupta
@nl
Rajan T Gupta
@sl
P106
P31
P496
0000-0002-2984-5010